Sysmex Corporation and Epigenomics AG Announce Strategic R&D Collaboration in Colorectal Cancer Diagnostics

BERLIN and KOBE, Japan, Jan. 22, 2009 (GLOBE NEWSWIRE) -- Sysmex Corporation (HQ: Kobe Japan; President: Hisashi Ietsugu) and Epigenomics AG (Frankfurt:ECX) (ISIN: DE000A0BVT96) announced today that they have signed a strategic research and development collaboration agreement in molecular diagnostics.